Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

The safety of etretinate as long-term therapy for psoriasis: results of the etretinate follow-up study.

The safety of etretinate as long-term therapy for psoriasis: results of the etretinate follow-up study. J Am Acad Dermatol. 1995 Jul; 33(1):44-52.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.